You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idelalisib

Showing 26 - 41 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +3 more
  • Idelalisib
  • Palo Alto, California
  • +1 more
Oct 19, 2018

DLBCL, Mediastinal B-cell Lymphoma Trial in Worldwide (Idelalisib, Rituximab, Ifosfamide)

Withdrawn
  • Diffuse Large B-Cell Lymphoma
  • Mediastinal B-cell Lymphoma
  • Idelalisib
  • +4 more
  • Lille, France
  • +6 more
Dec 7, 2018

Hodgkin Lymphoma Trial in New York, Houston, Seattle (Idelalisib)

Completed
Has Results
  • Hodgkin Lymphoma
  • Idelalisib
  • New York, New York
  • +2 more
Oct 19, 2018

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +5 more
Oct 19, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Idelalisib
  • +2 more
  • Huntsville, Alabama
  • +71 more
May 1, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Duarte, California
  • +79 more
Aug 5, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Chlorambucil, Obinutuzumab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Idelalisib
  • +2 more
  • Santa Barbara, California
  • +17 more
Oct 19, 2018

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion Trial in Worldwide (Idelalisib, Rituximab)

Terminated
Has Results
  • B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
  • Tucson, Arizona
  • +55 more
Oct 19, 2018

Relapsed/Refractory Mantle Cell Lymphoma Trial in United States (lenalidomide, idelalisib)

Completed
  • Relapsed/Refractory Mantle Cell Lymphoma
  • Chicago, Illinois
  • +3 more
Jan 26, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Bendamustine, Rituximab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Idelalisib
  • +3 more
  • Fullerton, California
  • +90 more
Oct 19, 2018

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Placebo, Rituximab, Idelalisib)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Placebo
  • +2 more
  • Huntsville, Alabama
  • +102 more
Oct 19, 2018

Amyloidosis Trial in Boston (Idelalisib)

Terminated
Has Results
  • Amyloidosis
  • Idelalisib
  • Boston, Massachusetts
    Boston Medical Center
Aug 23, 2017

Non Small Cell Lung Cancer, Metastasis, Recurrence Trial in Augusta (Pembrolizumab, Idelalisib)

Unknown status
  • Non Small Cell Lung Cancer
  • +2 more
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Sep 27, 2017

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Idelalisib
  • +3 more
  • Huntsville, Alabama
  • +143 more
Oct 19, 2018

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Idelalisib, Rituximab)

Approved for marketing
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
  • +7 more
Oct 27, 2014